arrow_back Back to App

Designating May as ALS Awareness Month

The U.S. Senate formally designated May as Amyotrophic Lateral Sclerosis (ALS) Awareness Month. The goal is to draw attention to this fatal disease, which affects tens of thousands of Americans, and to recognize the immense physical and financial burden borne by patients and their caregivers. The resolution emphasizes the Senate's commitment to supporting research, rapid access to treatment, and ensuring high-quality care for those affected.
Key points
Formal recognition of May as the month dedicated to increasing awareness of ALS, a neurodegenerative disease that shortens life to 2-5 years after diagnosis.
The Senate commits to working towards ensuring rapid access to effective treatments and high-quality support for patients and their caregivers.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_713
Sponsor: Sen. Coons, Christopher A. [D-DE]
Process start date: 2024-05-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating May 2024 as "ALS Awareness Month".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_713.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-05-23.

What are the main provisions?

Key points include:

  • Formal recognition of May as the month dedicated to increasing awareness of ALS, a neurodegenerative disease that shortens life to 2-5 years after diagnosis.
  • The Senate commits to working towards ensuring rapid access to effective treatments and high-quality support for patients and their caregivers.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Coons, Christopher A. [D-DE].

What is the latest detailed status?

The latest detailed status is: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (consideration: CR S4023; text: 5/23/2024 CR S3893)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health